Search

A Study of MK0657 in Parkinson's Disease Patients (0657-006)

Trial Phase 1 Completed Jan. 28, 2015

L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

Trial Phase 2 Unknown Jan. 26, 2015

Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism

Trial Phase 2 Completed Jan. 25, 2015

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa

Trial Phase 1 Completed Jan. 20, 2015

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Trial Phase 3 Completed Jan. 15, 2015

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

Trial Phase 3 Completed Jan. 15, 2015

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

Trial Phase 3 Completed Jan. 15, 2015

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Trial Phase 3 Completed Jan. 15, 2015

Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

Trial Phase 1 Completed Jan. 14, 2015

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide

Trial Phase 1 Completed Jan. 14, 2015

Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects

Trial Phase 1 Completed Jan. 13, 2015

A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Trial Phase 2 Completed Jan. 11, 2015

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Trial Phase 1 Completed Jan. 11, 2015

Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites

Trial Phase 1 Completed Jan. 8, 2015

A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects

Trial Phase 1 Completed Jan. 7, 2015

Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)

Trial Phase 1 Withdrawn Jan. 7, 2015

Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China

Trial Phase 3 Completed Dec. 22, 2014

Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease

Trial Phase 2 Terminated Dec. 17, 2014

PET Study of Non-Motor Symptoms of Parkinson Disease

Trial N/A Completed Dec. 1, 2014

Effect of Opicapone at Steady State on Warfarin Pharmacokinetics

Trial Phase 1 Completed Dec. 1, 2014